His primary areas of investigation include Antigen, Mycobacterium tuberculosis, Microbiology, Antibody and Mycobacterium bovis. His Antigen research includes themes of Pepsin and Virology. Morten Harboe interconnects Antiserum, Immunology, Peptide sequence and Bacteria in the investigation of issues within Mycobacterium tuberculosis.
His study in Microbiology is interdisciplinary in nature, drawing from both Mannan, Antigenicity, Borderline leprosy, Lepromatous leprosy and Immunoelectrophoresis. His Antibody study frequently intersects with other fields, such as Molecular biology. His biological study spans a wide range of topics, including Nocardia, Fibronectin binding and Mycobacterium.
Morten Harboe mainly investigates Immunology, Antigen, Antibody, Microbiology and Molecular biology. His Antigen study combines topics from a wide range of disciplines, such as Peptide sequence, Mycobacterium leprae, Lepromatous leprosy and Virology. His studies in Antibody integrate themes in fields like Radioimmunoassay and In vitro.
His Microbiology study combines topics in areas such as Mycobacterium bovis, Mycobacterium tuberculosis, Mycobacterium, Gene and Crossed immunoelectrophoresis. The various areas that he examines in his Mycobacterium tuberculosis study include Secretory protein, Operon, Polymerase chain reaction and Bacteria. His Molecular biology research also works with subjects such as
Morten Harboe spends much of his time researching Immunology, Antibody, Microbiology, Complement system and Alternative complement pathway. His work on Complement receptor, Complement, Immunity and Blood group antigens as part of general Immunology research is frequently linked to Type, bridging the gap between disciplines. His Antibody research incorporates elements of Prednisone, Leukocytosis, Antigen and Pathology.
His Antigen research is multidisciplinary, relying on both Old tuberculin, Mycobacterial antigen and Virology. His Microbiology research incorporates themes from Hemagglutination, Whole blood, Pneumonia, Neisseria meningitidis and Immune system. His research investigates the connection with Complement system and areas like Biochemistry which intersect with concerns in Myeloperoxidase.
His primary areas of study are Immunology, Classical complement pathway, Alternative complement pathway, Complement system and Antibody. His Immunology study frequently draws connections between adjacent fields such as MEDLINE. His Classical complement pathway research focuses on subjects like Complement receptor, which are linked to Complement component 5, Complement deficiency, Factor H and Anaphylatoxin.
The study incorporates disciplines such as Molecular biology and Cell biology in addition to Complement system. His Antibody research integrates issues from Mycobacterium bovis, Culture fluid, Antigen, Microbiology and Mycobacterial antigen. His research in Lectin pathway intersects with topics in Lectin, Mannan-binding lectin, Mannan, CFHR5 and Monoclonal antibody.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG.
M Harboe;T Oettinger;H G Wiker;I Rosenkrands.
Infection and Immunity (1996)
Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection.
R. Hernández-Pando;M. Jeyanathan;G. Mengistu;D. Aguilar.
The Lancet (2000)
ISOLATION AND PARTIAL CHARACTERIZATION OF MAJOR PROTEIN ANTIGENS IN THE CULTURE FLUID OF MYCOBACTERIUM TUBERCULOSIS
S Nagai;H G Wiker;M Harboe;M Kinomoto.
Infection and Immunity (1991)
Quantification of the Terminal Complement Complex in Human Plasma by an Enzyme-Linked Immunosorbent Assay Based on Monoclonal Antibodies against a Neoantigen of the Complex
T E Mollnes;T Lea;S S Frøland;M Harboe.
Scandinavian Journal of Immunology (1985)
Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG.
C. Abou-Zeid;T. L. Ratliff;H. G. Wiker;M. Harboe.
Infection and Immunity (1988)
The alternative complement pathway revisited.
Morten Harboe;Tom Eirik Mollnes.
Journal of Cellular and Molecular Medicine (2008)
Innate Immune Responses to Danger Signals in Systemic Inflammatory Response Syndrome and Sepsis
A. Castellheim;O.-L. Brekke;T. Espevik;M. Harboe.
Scandinavian Journal of Immunology (2009)
The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation
M. Harboe;G. Ulvund;L. Vien;M. Fung.
Clinical and Experimental Immunology (2004)
DUAL ROLE OF MANNAN‐BINDING PROTEIN IN INFECTIONS: ANOTHER CASE OF HETEROSIS?
P. Garred;M. Harboe;T. Oettinger.;C. Koch.
European Journal of Immunogenetics (1994)
Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG
M Harboe;S Nagai;M E Patarroyo;M L Torres.
Infection and Immunity (1986)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: